[Wegener's granulomatosis (morbus Wegener)]

MeSH terms

• Adult
• Anti-Infective Agents / therapeutic use
• Anti-Inflammatory Agents / administration & dosage
• Anti-Inflammatory Agents / therapeutic use
• Azathioprine / administration & dosage
• Azathioprine / therapeutic use
• Cyclophosphamide / administration & dosage
• Cyclophosphamide / therapeutic use
• Diagnosis, Differential
• Drug Therapy, Combination
• Follow-Up Studies
• Granulomatosis with Polyangiitis* / complications
• Granulomatosis with Polyangiitis* / diagnosis
• Granulomatosis with Polyangiitis* / diagnostic imaging
• Granulomatosis with Polyangiitis* / drug therapy
• Humans
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / therapeutic use
• Male
• Methotrexate / administration & dosage
• Methotrexate / therapeutic use
• Methylprednisolone Hemisuccinate / administration & dosage
• Methylprednisolone Hemisuccinate / therapeutic use
• Prednisone / administration & dosage
• Prednisone / therapeutic use
• Prognosis
• Radiography, Thoracic
• Recurrence
• Time Factors
• Treatment Outcome
• Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use